Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141,965 | -54,659 | -74,352 | -10,233 | -7 |
| Depreciation Amortization | 627 | 423 | 265 | 11 | N/A |
| Accounts receivable | 8,053 | 799 | -10,612 | N/A | N/A |
| Accounts payable and accrued liabilities | 4,305 | 10,210 | 395 | 87 | N/A |
| Other Working Capital | 24,792 | -8,331 | 9,981 | 306 | N/A |
| Other Operating Activity | 26,985 | -3,490 | 30,311 | 8,005 | 0 |
| Operating Cash Flow | $-77,203 | $-55,048 | $-44,012 | $-1,824 | $-7 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,292 | -628 | -1,062 | -693 | N/A |
| Purchase Of Investment | -132,259 | -49,347 | 0 | N/A | N/A |
| Sale Of Investment | 70,277 | 8,446 | 0 | N/A | N/A |
| Other Investing Activity | -1 | -2 | -159 | -1,053 | 0 |
| Investing Cash Flow | $-63,275 | $-41,531 | $-1,221 | $-1,746 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 150 | N/A |
| Common Stock Issued | 135,973 | 2,215 | 129,259 | 56,741 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 61 | 7 |
| Financing Cash Flow | $135,973 | $2,215 | $129,259 | $56,952 | $7 |
| Beginning Cash Position | 43,044 | 137,408 | 53,382 | N/A | N/A |
| End Cash Position | 38,539 | 43,044 | 137,408 | 53,382 | N/A |
| Net Cash Flow | $-4,505 | $-94,364 | $84,026 | $53,382 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,203 | -55,048 | -44,012 | -1,824 | -7 |
| Capital Expenditure | -1,292 | -628 | -1,062 | -693 | N/A |
| Free Cash Flow | -78,495 | -55,676 | -45,074 | -2,517 | -7 |